Cardlytics (CDLX) IPO Opens 7% Lower
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/11/2026
- S&P 500, Dow futures attempt recovery ahead of inflation report
- Oracle raises full year profit guidance, stock rises after hours
- Oil surges 6%, Brent and US crude both surpass $100 on more tanker attacks
- Analysts split on Apple after foldable iPhone Duo debut
- JPMorgan upgrades Meta on AI models and agents, sees 'meaningful headroom'
- White House copper tariff plan stalls amid affordability concerns, sources say
- Micron's Taiwan workers to get rewards worth up to 68 months of pay
- Crude Inventory 0.4M Barrels Last Week - EIA
- Vertiv shares drop on acquisition skepticism, AI pullback
- S&P 500, Dow futures attempt recovery ahead of inflation report
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Cardlytics (Nasdaq: CDLX) to Ring The Nasdaq Stock Market Opening Bell in Celebration of its IPO
February 9, 2018 6:00 AM ESTADVISORY, Feb. 09, 2018 (GLOBE NEWSWIRE) --
What:Â Cardlytics (Nasdaq: CDLX), a purchase intelligence platform that helps make marketing more relevant and measurable, will visit the Nasdaq MarketSite in Times Square, in celebration of its initial public offering (IPO).
In honor of the occasion, Scott Grimes, CEO & Co-Founder & Lynne Laube, COO & Co-Founder, will ring the Opening Bell.Â
Where:Nasdaq MarketSite 4 Times Square 43rd & Broadway Broadcast Studio
When:Friday, February 9, 2018 9:15 a.m. to 9:30 a.m. ETÂ Â Â Â
Cardlytics Media... More
Cardlytics Announces Pricing of Initial Public Offering
February 8, 2018 6:41 PM ESTATLANTA, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Cardlytics, Inc., a purchase intelligence platform that helps make marketing more relevant and measurable, today announced the pricing of its initial public offering of 5,400,000 shares of common stock at a price to the public of $13.00 per share, before underwriting discounts and commissions. All of the shares of common stock are being offered by Cardlytics. In addition, Cardlytics has granted the underwriters a 30-day option to purchase up to an additional 810,000 shares of common stock. Cardlytics common stock is expected to begin trading on the Nasdaq Global Market under the ticker symbol CDLX on February 9, 2018. The... More
